Literature DB >> 3094545

Discordant effects of prednisone on anticardiolipin antibodies and the lupus anticoagulant.

R H Derksen, D Biesma, B N Bouma, F H Gmelig Meyling, L Kater.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3094545     DOI: 10.1002/art.1780291021

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  12 in total

Review 1.  Pregnancy and antibodies to phospholipids.

Authors:  M J Walport
Journal:  Ann Rheum Dis       Date:  1989-10       Impact factor: 19.103

Review 2.  Antiphospholipid syndrome: linking many specialties.

Authors:  G R Hughes; R A Asherson; M A Khamashta
Journal:  Ann Rheum Dis       Date:  1989-05       Impact factor: 19.103

3.  Lupus anticoagulant: clinical significance in anticardiolipin positive patients with systemic lupus erythematosus.

Authors:  N J McHugh; D A Moye; I E James; M Sampson; P J Maddison
Journal:  Ann Rheum Dis       Date:  1991-08       Impact factor: 19.103

4.  Antiphospholipid antibodies and Mycoplasma pneumoniae infection.

Authors:  N Snowden; P B Wilson; M Longson; R S Pumphrey
Journal:  Postgrad Med J       Date:  1990-05       Impact factor: 2.401

5.  Prospective study of fluctuations of lupus anticoagulant activity and anticardiolipin antibody titre in patients with systemic lupus erythematosus.

Authors:  H J Out; M van Vliet; P G de Groot; R H Derksen
Journal:  Ann Rheum Dis       Date:  1992-03       Impact factor: 19.103

Review 6.  Treatment of the antiphospholipid syndrome.

Authors:  J C Piette; M Karmochkine; T Papo; L T Du; C Francès; B Wechsler
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

7.  Fluctuations of anticardiolipin antibody levels in patients with systemic lupus erythematosus: a prospective study.

Authors:  H J Out; P G de Groot; P Hasselaar; M dan Vliet; R H Derksen
Journal:  Ann Rheum Dis       Date:  1989-12       Impact factor: 19.103

8.  Clinical importance of persistence of anticardiolipin antibodies in systemic lupus erythematosus.

Authors:  Y Ishii; K Nagasawa; T Mayumi; Y Niho
Journal:  Ann Rheum Dis       Date:  1990-06       Impact factor: 19.103

9.  Heterogeneity of binding reactivity to different phospholipids of antibodies from patients with systemic lupus erythematosus (SLE) and with syphilis.

Authors:  S Loizou; C G Mackworth-Young; C Cofiner; M J Walport
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

10.  Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients.

Authors:  R H Derksen; P Hasselaar; L Blokzijl; F H Gmelig Meyling; P G De Groot
Journal:  Ann Rheum Dis       Date:  1988-05       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.